Jeanie Herbert | Senior Director of Investor Relations and Corporate Communications |
Mark Foley | President and Chief Executive Officer |
Toby Schilke | Chief Financial Officer |
Dr. Abhay Joshi | Chief Operating Officer and President of R&D and Product Operations |
Dustin Sjuts | Chief Commercial Officer of Aesthetics and Therapeutics |
Jacob Hughes | Wells Fargo Securities |
Balaji Prasad | Barclays |
Annabel Samimy | Stifel |
Difei Yang | Mizuho Securities |
Tim Lugo | William Blair |
Seamus Fernandez | Guggenheim |
Welcome to the Revance Therapeutics First Quarter 2020 Financial Results and Corporate Update Conference Call [Operator Instructions].
As a reminder, this call is being recorded today, May 7, 2020.
I would now like to turn the conference over to Jeanie Herbert, Senior Director of Investor Relations and Corporate Communications of Revance. Please go ahead, ma'am.
Thank you, Stacy.